Screening with TargetNet revealed potential interactions between SGLT2i and the experimentally validated proteins DGAT1, TYMS, and PTGS2, suggesting a connection between NAFLD and AF through inflammatory pathways. The gene discussed is DGAT1; the disease is metabolic dysfunction-associated steatotic liver disease.